上海医药(SH 601607,收盘价:18.13元)4月28日晚间发布一季度业绩公告称,2025年第一季度营收约707.63亿元,同比增加0.87%;归属于上市公司股东的净利润约13.33亿元,同比减少13.56%;基本每股收益0.36元,同比减少14.29%。(文章来源:每日经济新闻)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.